BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25240410)

  • 1. Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options.
    Chau NG; Rabinowits G; Haddad RI
    Curr Treat Options Oncol; 2014 Dec; 15(4):595-610. PubMed ID: 25240410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
    Fung N; Faraji F; Kang H; Fakhry C
    Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.
    Nichols AC; Lang P; Prisman E; Berthelet E; Tran E; Hamilton S; Wu J; Fung K; de Almeida JR; Bayley A; Goldstein DP; Eskander A; Husain Z; Bahig H; Christopoulous A; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Mendez A; Winquist E; Read N; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Corsten M; Rajaraman M; Johnson-Obaseki S; Eapen L; Odell M; Chandarana S; Banerjee R; Dort J; Matthews TW; Hart R; Kerr P; Dowthwaite S; Gupta M; Zhang H; Wright J; Parker C; Wehrli B; Kwan K; Theurer J; Palma DA
    BMC Cancer; 2020 Feb; 20(1):125. PubMed ID: 32059705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.
    Maxwell JH; Grandis JR; Ferris RL
    Annu Rev Med; 2016; 67():91-101. PubMed ID: 26332002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer of the Oropharynx and the Association with Human Papillomavirus.
    Rettig EM; Sethi RKV
    Hematol Oncol Clin North Am; 2021 Oct; 35(5):913-931. PubMed ID: 34244016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point/Counterpoint: Do We De-escalate Treatment of HPV-Associated Oropharynx Cancer Now? And How?
    Wirth LJ; Burtness B; Nathan CO; Grégoire V; Richmon J
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():364-372. PubMed ID: 31099643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative Treatment of Oropharyngeal Cancer in the Era of Human Papillomavirus.
    Geiger JL; Ku JA
    Curr Treat Options Oncol; 2019 Feb; 20(3):20. PubMed ID: 30771020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials.
    Bhatia A; Burtness B
    J Clin Oncol; 2015 Oct; 33(29):3243-50. PubMed ID: 26351343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has the time come for de-escalation in the management of oropharyngeal carcinoma?
    Durkova J; Boldis M; Kovacova S
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Dec; 163(4):293-301. PubMed ID: 31796941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?
    Samuels SE; Eisbruch A; Beitler JJ; Corry J; Bradford CR; Saba NF; van den Brekel MW; Smee R; Strojan P; Suárez C; Mendenhall WM; Takes RP; Rodrigo JP; Haigentz M; Rapidis AD; Rinaldo A; Ferlito A
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):2877-94. PubMed ID: 26463714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
    Liederbach E; Kyrillos A; Wang CH; Liu JC; Sturgis EM; Bhayani MK
    Int J Cancer; 2017 Feb; 140(3):504-512. PubMed ID: 27667729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimodality therapy for HPV-positive oropharyngeal cancer: A population-based study: Trimodality therapy for HPV+ OPC.
    Sanford NN; Hwang WL; Pike LRG; Lam AC; Royce TJ; Mahal BA
    Oral Oncol; 2019 Nov; 98():28-34. PubMed ID: 31536843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study.
    Lefevre M; Rousseau A; Rayon T; Dalstein V; Clavel C; Beby-Defaux A; Pretet JL; Soussan P; Polette M; Lacau Saint Guily J; Birembaut P;
    Br J Cancer; 2017 Jan; 116(3):362-369. PubMed ID: 28072763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations in Human Papillomavirus-Associated Oropharyngeal Cancer Screening: A Review.
    Day AT; Fakhry C; Tiro JA; Dahlstrom KR; Sturgis EM
    JAMA Otolaryngol Head Neck Surg; 2020 Jul; 146(7):656-664. PubMed ID: 32379293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
    Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial.
    Posner MR; Lorch JH; Goloubeva O; Tan M; Schumaker LM; Sarlis NJ; Haddad RI; Cullen KJ
    Ann Oncol; 2011 May; 22(5):1071-1077. PubMed ID: 21317223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy.
    Ihloff AS; Petersen C; Hoffmann M; Knecht R; Tribius S
    Oral Oncol; 2010 Oct; 46(10):705-11. PubMed ID: 20843732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Good cancer gone bad': a narrative review of HPV oropharyngeal cancer and potential poor outcomes.
    Alabi O; O'Neill JP
    Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2185-2191. PubMed ID: 32333138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.